ABSTRACT
Anesthetic management in swine (Sus scrofa) is challenging due to behavioral characteristics and the species’ predisposition to malignant hyperthermia (MH), frequently triggered by inhalational agents. Total intravenous anesthesia (TIVA) emerges as a safe alternative for minimizing this risk. This report describes and justifies the use of a TIVA protocol in a 45-kg pig undergoing umbilical hernia repair, emphasizing its safety, physiological stability, and suitability for field conditions. The animal, classified as ASA II, received pre-anesthetic medication with Azaperone (5mg/kg, IM), Ketamine (10mg/kg, IM), and Butorphanol (0.2mg/kg, IM). Induction was achieved with Propofol (2mg/kg, IV) associated with Fentanyl (5µg/kg, IV). Anesthesia was maintained with a continuous Propofol infusion initially at 0.1mg/kg/min, later reduced to 0.05mg/kg/min based on the clinical response. Multiparametric monitoring revealed stable parameters (HR 78 bpm, SpO₂ 99%, RR 28 rpm, BT 36.1°C). Analgesia was ensured through intraoperative multimodal administration of Butorphanol/Fentanyl and postoperative Flunixin meglumine (2.2mg/kg, IV). Ceftriaxone (30mg/kg, IV) was used as prophylactic antibiotic therapy. The protocol proved safe and effective, ensuring adequate analgesia and physiological stability, supporting its applicability in field anesthesia for swine.
Keywords:
TIVA; swine; multimodal analgesia; animal welfare
RESUMO
O manejo anestésico em suínos (Sus scrofa) apresenta desafios devido ao seu comportamento natural e à predisposição genética à hipertermia maligna (HM), frequentemente desencadeada por agentes inalantes. A anestesia total intravenosa (TIVA) é uma alternativa segura para mitigar o risco de HM. O objetivo deste relato é descrever e justificar a escolha e o desempenho de um protocolo de TIVA em um suíno de 45kg submetido à correção cirúrgica de hérnia umbilical, destacando sua segurança, estabilidade fisiológica e aplicabilidade em condições de campo. O animal foi classificado como ASA II. A medicação pré-anestésica (MPA) consistiu em azaperone (5mg/kg, IM), cetamina (10mg/kg, IM) e butorfanol (0,2mg/kg, IM). A indução foi realizada com propofol (2mg/kg, IV) e fentanil (5µg/kg, IV). A manutenção se deu por infusão contínua de propofol, iniciada em 0,1mg/kg/min e ajustada para 0,05mg/kg/min. O monitoramento multiparamétrico demonstrou estabilidade hemodinâmica: frequência cardíaca (FC) média de 78bpm, saturação periférica de oxigênio (SpO2) de 99%, frequência respiratória (FR) de 28mrpm e temperatura corporal (TC) de 36,1ºC. O controle da dor foi garantido pela analgesia multimodal intraoperatória (butorfanol/fentanil) e por analgesia pós-operatória com flunixin meglumina (2,2mg/kg, IV), associada à antibioticoprofilaxia com ceftriaxona (30mg/kg, IV). Conclui-se que o protocolo de TIVA demonstrou-se seguro, eficaz e proporcionou analgesia e estabilidade fisiológica adequadas para o procedimento cirúrgico, configurando-se como uma alternativa eficiente para suínos em contextos clínicos a campo.
Palavras-chave:
TIVA; suínos; analgesia multimodal; bem-estar animal
INTRODUCTION
According to Santana (2021), swine are globally recognized as a species of great agricultural relevance. However, beyond their intensive rearing for food production, pigs also play an important role in research, being used as experimental models for clinical and surgical techniques in medicine, since they share anatomical and physiological similarities with humans.
According to Nunes (2007), the main challenge in the experimental use of swine is their natural behavior, which makes handling and immobilization during testing difficult. To mitigate this, and to reduce animal stress, many procedures are performed with the aid of sedative techniques or general anesthesia, particularly in the case of prolonged surgeries.
The use of anesthetic techniques is highly relevant in experimental swine practice. According to Rosenberg (2015), pigs may present a genetic predisposition to malignant hyperthermia associated with mutations in the ryanodine receptor gene (RYR1), which leads to uncontrolled calcium release in skeletal muscle and excessive muscle contraction. This condition can be triggered by stress or exposure to volatile anesthetics such as halothane, isoflurane, sevoflurane, and desflurane.
The present study aims to report the case of an anesthetic procedure performed in a swine (Sus scrofa) submitted to total intravenous anesthesia (TIVA) with azaperone, ketamine, butorphanol, and maintenance with propofol for corrective herniorrhaphy surgery.
The procedure was performed in the city of Concórdia, SC, in a swine production facility of the Federal Institute of Santa Catarina, Concórdia Campus, on June 12, 2025. The patient was a pig (Sus scrofa), AgPIC 337 lineage, approximately three months old, weighing 45 kilograms on the day of the procedure.
The animal presented a circular, pendulous swelling in the umbilical region, consistent with the clinical manifestation of an umbilical hernia. The diagnosis was established through inspection and palpation, as recommended by Fubini and Ducharme (2017). Imaging examinations were not performed due to logistical constraints inherent to field conditions. An umbilical herniorrhaphy surgery was chosen to correct the condition. The animal was restrained for preoperative blood collection for a complete blood count, which was performed on campus prior to the surgical procedure and showed values within the expected range for the species.
The animal was classified according to the American Society of Anesthesiologists (ASA) system, and after evaluation, it was placed in ASA 2, indicating mild systemic disease. For the herniorrhaphy surgery, an anesthetic protocol was developed to ensure sedation, general anesthesia, and analgesia, as detailed below.
Sedation was achieved with Azaperone, a butyrophenone widely used in swine to promote tranquility and reduce stress, at a dose of 2mg/kg (2mL, IM). As part of the pre-anesthetic medication, Ketamine (5mg/kg, 2mL, IM)-a dose predetermined according to the protocol and consistent with the recommendations of Malavasi et al. (2024) was administered as a dissociative anesthetic providing immobilization and analgesia. Butorphanol (0.1mg/kg, 0.45mL, IM), an opioid offering effective analgesia, was also included. All three drugs were combined in the same syringe and administered simultaneously to facilitate handling and ensure a smooth and efficient pre-anesthetic protocol. Following administration, the animal was placed in a pen to allow the sedative effects to develop adequately as seen in Fig. 1. Butorphanol was included to provide sedation and mild analgesia during the restraint phase, and by the time induction began, its μ-antagonist effect had already started to decline, permitting appropriate fentanyl activity, as described by Malavasi et al. (2024) and Chang et al. (2021).
Adequate sedation was achieved within 15 minutes, assessed through posture, response to stimuli, vocalization, and ease of handling, as shown in Fig. 2. After confirming the desired sedative effect, the animal was taken to the procedure room as seen in figure 3, where venous access was established in the auricular vein for drug administration. Anesthetic induction was then performed intravenously with propofol at 2mg/kg (9mL total volume). As a co-induction agent, fentanyl, a fast-acting opioid, was administered at 5µg/kg (4.5mL total volume, IV), titrated over two minutes. Fentanyl was included to provide intraoperative analgesia from the onset of anesthesia and to allow for a reduced propofol induction dose.
Anesthesia was maintained with Propofol administered continuously via a portable universal syringe pump, allowing slow and controlled infusion. The infusion was initiated at 0.1mL/kg/min (27mL total) and, as the anesthetic plane stabilized based on the absence of reflexes, hemodynamic and respiratory stability, and lack of voluntary movements the rate was reduced to 0.05mL/kg/min (13.5mL total).
The animal was monitored using a portable RZ800VET multiparameter monitor seen in figure 4. This device records and displays electrocardiographic curves in D1 (Lead I), D2 (Lead II), and D3 (Lead III) modes, enabling real-time monitoring of cardiac electrical activity, essential for cardiovascular evaluation during anesthesia or in critical clinical situations. Additionally, the device records plethysmographic SpO₂ curves, reflecting peripheral blood volume changes, providing complementary information on oxygen saturation and aiding early detection of perfusion and oxygenation alterations. Respiratory rate was assessed by observing thoracic movements.
Rectal temperature was measured using a clinical thermometer appropriate for the species. Heart rate (HR, bpm), respiratory rate (RR, rpm), and body temperature (BT, °C) recorded during the procedure are presented in the table below. The first 25 minutes were dedicated to anesthetic stabilization and equipment setup, which explains the initial period before consistent parameter recording began.
During monitoring, physiological parameters remained within acceptable limits. Heart rate ranged from 60 to 98 bpm, showing a gradual decline after peaking at 40 minutes, followed by recovery toward the end of the procedure findings compatible with the cardiovascular depressive effects of propofol and with transient responses to surgical stimulation. Respiratory rate varied between 14 and 40 rpm, with both reductions and peaks observed. Although propofol and fentanyl are known to cause dose-dependent respiratory depression, the transient increases in respiratory rate may be attributed to responses to surgical stimuli, tissue manipulation, or mild hypercapnia.
Body temperature remained stable between 35.3°C and 36.7°C throughout most of the procedure, indicating adequate thermal regulation despite field conditions. A temperature decrease was noted at 125 minutes, which can be attributed to expected intraoperative heat loss, the open and naturally cooler field environment, and the absence of active warming devices. Even so, values remained within clinically acceptable limits for swine under anesthesia.
The analgesic protocol was designed to ensure animal comfort and minimize pain-related physiological responses. Pre-anesthetic medication included Butorphanol (0.1mg/kg, IM), providing analgesia from the onset of anesthesia, reducing the need for additional sedatives such as Ketamine and Azaperone. During induction, Fentanyl (5mcg/kg, IV) was administered, ensuring potent and rapid analgesia. The association of fentanyl with propofol reduced drug requirements and enhanced intraoperative analgesia.
In the postoperative period, Ceftriaxone (30mg/kg, 5.8mL, IV) and Flunixin meglumine (2.2mg/kg, 1mL, IV) were administered. Ceftriaxone, a broad-spectrum antibiotic, was given to prevent secondary infections, while Flunixin, a nonsteroidal anti-inflammatory drug (NSAID), was essential for postoperative analgesia.
CONCLUSIONS
This study concluded that total intravenous anesthesia (TIVA) in swine, using a protocol composed of Azaperone, Ketamine, Butorphanol, Propofol, and Fentanyl, provided safe and effective anesthesia with stable physiological parameters throughout the procedure. The drug combination ensured smooth sedation, induction, and maintenance of anesthesia, with no significant adverse effects observed. Continuous multiparameter monitoring enabled real-time evaluation of physiological status, contributing to anesthetic safety.
Adequate analgesia was inferred from the absence of autonomic responses (such as tachycardia or increases in respiratory rate), absence of voluntary movements or withdrawal reactions, hemodynamic stability, and lack of vocalization during tissue manipulation. Additionally, the consistent loss of palpebral and mandibular reflexes confirmed that the anesthetic depth was appropriate for the species and for the surgical intervention performed.
Postoperative analgesia with an opioid-NSAID combination further contributed to animal welfare and recovery quality. Therefore, when properly planned and monitored, TIVA represents a viable and effective anesthetic approach for swine, minimizing risks such as malignant hyperthermia and promoting greater safety, stability, and welfare in field surgical conditions.
REFERENCES
- CHANG, L.J.; KO, J.C.; WEIL, A.B.; WENG, H.Y. Comparison of anesthetic and cardiorespiratory effects of tiletamine-zolazepam-detomidine-butorphanol, tiletamine-zolazepam-xylazine-butorphanol, and ketamine-detomidine-butorphanol in pigs. J. Am. Vet. Med. Assoc., v.258, p.883-891, 2021.
- FUBINI, S.L.; DUCHARME, N. Farm animal surgery St. Louis: Elsevier Health Sciences, 2017. 606p.
- MALAVASI, L. et al (Ed.). Swine. KUNT, A.; GRIMM, L.A.; LAMONT, W.J. Veterinary anesthesia and analgesia: Lumb and Jones. 6.ed. Hoboken: John Wiley & Sons, 2024. p.2709-2742.
- NUNES, S.; BERG, L.; RAITTINEN, L.P. et al Deep sedation with dexmedetomidine in a porcine model does not compromise the viability of free microvascular flap as depicted by microdialysis and tissue oxygen tension. Anaesth. Analg., v.105, n.3, 2007.
- ROSENBERG, Henry; POLLOCK, Neil; SCHIEMANN, Anja; BULGER, Teresa; STOWELL, Kathryn. Malignant hyperthermia: a review. Orphanet Journal of Rare Diseases, v. 10, p. 93, 2015.
- SANTANA, Isabella Nogueira. Efeitos do propofol associado ou não à xilazina ou dexmedetomidina na indução da anestesia em suínos pré-medicados com cetamina e midazolam e mantidos com isofluorano. 2021. Dissertação (Mestrado) - Universidade Estadual Paulista, Jaboticabal, 2021.





Source: Author’s collection, 2025.
Source: Author’s collection, 2025.
Source: Author’s collection, 2025.
Source: Author’s collection, 2025.